Theolytics

About:

Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.

Website: https://www.theolytics.com/

Twitter/X: theolytics

Top Investors: Innovate UK, Oxford Science Enterprises, M Ventures, Epidarex Capital, Taiho Ventures

Description:

Theolytics is a clinical stage biotechnology company harnessing viruses to combat disease. A step-change in the adenoviral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing an internal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.